Cureos Furgghorn Study

The FURGGHORN Study

On the 13th March, the first patient was enrolled on the FURGGHORN Study. This study assesses patients with wet macular degeneration which are switched to Vabysmo. This investigator-initiated study will include 150 participants at over 10 sites across Australia.